These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7511803)

  • 1. Effects of 4-MAPC, a 5 alpha-reductase inhibitor, and cyproterone acetate on regrowth of the rat ventral prostate.
    Shao TC; Kong A; Cunningham GR
    Prostate; 1994 Apr; 24(4):212-20. PubMed ID: 7511803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-MAPC, a 5 alpha-reductase inhibitor, reduces rat ventral prostate weight, DNA, and prostatein concentrations.
    Ghusn HF; Shao TC; Klima M; Cunningham GR
    J Androl; 1991; 12(5):315-22. PubMed ID: 1765567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of 5 alpha-reductase inhibition and castration on androgen-regulated gene expression in rat prostate.
    Rittmaster RS; Magor KE; Manning AP; Norman RW; Lazier CB
    Mol Endocrinol; 1991 Jul; 5(7):1023-9. PubMed ID: 1719382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of androstenedione-induced stimulation of androgen-sensitive parameters in the rat prostate by combination of Flutamide and 4-MA.
    Martel C; Trudel C; Couet J; Labrie C; Bélanger A; Labrie F
    Mol Cell Endocrinol; 1993 Feb; 91(1-2):43-9. PubMed ID: 8472853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of proliferative lesions of ventral prostate, seminal vesicle, and other accessory sex glands in rats by N-methyl-N-nitrosourea: effect of castration, pretreatment with cyproterone acetate and testosterone propionate and rat strain.
    Bosland MC; Prinsen MK; Rivenson A; Silverman J; Fiala E; Williams GM; Kroes R; Weisburger JH
    Prostate; 1992; 20(4):339-53. PubMed ID: 1535126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-androgen effects of the aromatase inhibitor, atamestane.
    Shao TC; Marcelli M; Kong A; Cunningham GR
    J Androl; 1995; 16(2):100-7. PubMed ID: 7559139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of finasteride on the rat ventral prostate.
    Shao TC; Kong A; Marafelia P; Cunningham GR
    J Androl; 1993; 14(2):79-86. PubMed ID: 8390428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of an antiandrogen and a 5 alpha-reductase inhibitor: a further step towards total androgen blockade?
    Labrie C; Trudel C; Li S; Martel C; Couêt J; Labrie F
    Endocrinology; 1991 Jul; 129(1):566-8. PubMed ID: 2055205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic progestins stimulate prostatic binding protein messenger RNAs in the rat ventral prostate.
    Labrie C; Simard J; Zhao HF; Pelletier G; Labrie F
    Mol Cell Endocrinol; 1990 Jan; 68(2-3):169-79. PubMed ID: 2138099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 5-alpha-reductase inhibitor, 4-MAPC, on testicular descent in male rat.
    Ngyuen MM; Lemmi CA; Rajfer J
    J Urol; 1991 May; 145(5):1096-8. PubMed ID: 2016800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of castration and androgen treatment on the synthesis of prostatic binding protein and the concentration of its mRNA in the rat ventral prostate.
    Bossyns D; Delaey B; Rombauts W; Heyns W
    J Steroid Biochem; 1986 Mar; 24(3):661-8. PubMed ID: 3702445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen-independent effects of prolactin on the different lobes of the immature rat prostate.
    Reiter E; Lardinois S; Klug M; Sente B; Hennuy B; Bruyninx M; Closset J; Hennen G
    Mol Cell Endocrinol; 1995 Jul; 112(1):113-22. PubMed ID: 7589778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
    Wilson MJ; Ludowese C; Sinha AA; Estensen RD
    Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action and pure antiandrogenic properties of flutamide.
    Labrie F
    Cancer; 1993 Dec; 72(12 Suppl):3816-27. PubMed ID: 8252497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of androgen-dependent gene expression by the adrenal precursors dehydroepiandrosterone and androstenedione in the rat ventral prostate.
    Labrie C; Simard J; Zhao HF; Belanger A; Pelletier G; Labrie F
    Endocrinology; 1989 Jun; 124(6):2745-54. PubMed ID: 2524377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of prostate gene expression and tissue weight changes as monitors of antiandrogen activity in GNRH-inhibited rats.
    Nellemann C; Lefevre PA; Ashby J
    Birth Defects Res B Dev Reprod Toxicol; 2003 Aug; 68(4):344-54. PubMed ID: 14666997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic luminal cell differentiation and prostatic steroid-binding protein (PBP) gene expression are differentially affected by neonatal castration.
    Janulis L; Nemeth JA; Yang T; Lang S; Lee C
    Prostate; 2000 May; 43(3):195-204. PubMed ID: 10797494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of castration, DES, flutamide, and the 5 alpha-reductase inhibitor, MK-906, on the growth of the Dunning rat prostatic carcinoma, R-3327.
    Brooks JR; Berman C; Nguyen H; Prahalada S; Primka RL; Rasmusson GH; Slater EE
    Prostate; 1991; 18(3):215-27. PubMed ID: 1850515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of estradiol on prostate epithelial cells in the castrated rat.
    Pelletier G
    J Histochem Cytochem; 2002 Nov; 50(11):1517-24. PubMed ID: 12417618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinclozolin and p,p'-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism.
    Kelce WR; Lambright CR; Gray LE; Roberts KP
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):192-200. PubMed ID: 9007049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.